DRAFT
Patent Lens > Technology Landscapes > Human Telomerase Gene (cancer diagnostics and stem cell uses)

In the following section of this report, an overview of the patent landscape is presented.  Attention is drawn to the key patents – those that appear to have the broadest claims.  For a number of reasons, the report analyses mainly patents sought or granted in the United States:  the largest key player, Geron, is based in the United States, U.S. patents are readily obtained, the law regarding claim interpretation is most well developed.  In contrast, because patents granted by the European Patent Office are interpreted according to each country’s laws, the body of patent law isn’t homogeneous. 

The documents discussed in this report are a mix of patent and patent applications.  For patent applications, caution is warranted when evaluating the claim scope because the claims have not been examined and may differ if and when granted. 

The format of the survey generally contains a summary of the patent description, a listing of the most relevant independent claim(s) and discussion of the claim meaning. 

Comments (0)